Profil
Kate Tansey Chevlen currently works at Spyre Therapeutics, Inc., as Chief Commercial Officer from 2026.
Ms. Chevlen also formerly worked at Amgen, Inc., as VP & Global Marketing Head-Immunology.
Ms. Chevlen received her undergraduate degree from Brandeis University and Masters Business Admin degree from Johnson Graduate School of Management.
Postes actifs de Kate Chevlen
| Sociétés | Poste | Début |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 12/01/2026 |
Anciens postes connus de Kate Chevlen
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2026 |
Formation de Kate Chevlen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















